* Permission to use quotations was neither sought nor obtained.
About Datascope Corp.
Datascope Corp. is the global leader of intra-aortic balloon counterpulsation and a diversified medical device company that develops, manufactures and markets proprietary products for clinical health care markets in interventional cardiology and radiology, cardiovascular and vascular surgery, anesthesiology, emergency medicine and critical care. The Company's products are sold throughout the world through direct sales representatives and independent distributors. Founded in 1964, Datascope is headquartered in Montvale, New Jersey. For news releases, webcasts and other Company information please visit Datascope's website, http://www.datascope.com.
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act. All statements
that address expectations or projections about the future, including
statements about Datascope's strategy for growth, product development,
market and growth opportunities, and future performance are forward-looking
statements. These statements are not guarantees of future performance and
involve a number of risks, uncertainties and assumptions. Important factors
that could cause actual results to differ materially from our expectations
are disclosed in our filings with the United States Securities and Exchange
Commission ("SEC"). These factors include, but are not limited to, the risk
that NetGuard does not have the potential to create a new, significant
market in monitoring currently unmonitored patients, that Datascope is not
the first company to address this market, that NetGuard and other new
products offered or anticipated to be offered by Datascope will not be a
significant opportunity for new growth or may not be accepted in the
marketplace, and that market conditions may ch
|SOURCE Datascope Corp.|
Copyright©2007 PR Newswire.
All rights reserved